The PARTNER Publications Office and Columbia University Medical Center, 177 Ft. Washington Ave, Room 501, New York, NY 10032, USA.
The PARTNER Publications Office and Columbia University Medical Center, 177 Ft. Washington Ave, Room 501, New York, NY 10032, USA
Eur Heart J. 2014 Jun 21;35(24):1599-607. doi: 10.1093/eurheartj/eht376. Epub 2013 Oct 30.
Cardiac conduction disturbances, including a left bundle branch block (LBBB), occur frequently following transcatheter aortic valve replacement (TAVR) and may be associated with adverse clinical events. This analysis examines the incidence and implications of new onset, persistent LBBB in patients undergoing TAVR with a balloon-expandable valve.
Patients undergoing TAVR in the Placement of Aortic Transcatheter Valves (PARTNER) trial and continued access registries with baseline and discharge/7-day electrocardiograms were included. Prior permanent pacemaker implantation (PPI) and baseline intraventricular conduction abnormalities were exclusion criteria. Predictors of new LBBB were identified and outcomes compared between patients with and without new LBBB. New LBBB occurred in 121 of 1151 (10.5%) patients and persisted in more than half at 6 months to 1 year. The only predictor of new LBBB was prior coronary artery bypass grafting. New LBBB was not associated with significant differences in 1-year mortality, cardiovascular mortality, repeat hospitalization, stroke, or myocardial infarction. However, it was associated with increased PPI during hospitalization (8.3 vs 2.8%, P = 0.005) and from discharge to 1 year (4.7 vs. 1.5%, P = 0.01). The ejection fraction failed to improve after TAVR in patients with new LBBB and remained lower at 6 months to 1 year (52.8 vs. 58.1%, P < 0.001).
Persistent, new-onset LBBB occurred in 10.5% of patients without intraventricular baseline conduction who underwent TAVR in the PARTNER experience. New LBBB was not associated with death, repeat hospitalization, stroke, or myocardial infarction at 1 year, but was associated with a higher rate of PPI and failure of left ventricular ejection fraction to improve.
经导管主动脉瓣置换术(TAVR)后常发生心脏传导障碍,包括左束支传导阻滞(LBBB),并可能与不良临床事件相关。本分析检查了在接受球囊扩张瓣膜 TAVR 的患者中新发持续性 LBBB 的发生率和意义。
本研究纳入了在经导管放置主动脉瓣(PARTNER)试验和持续接入注册研究中接受 TAVR 且具有基线和出院/7 天心电图的患者。既往永久性起搏器植入(PPI)和基线室内传导异常为排除标准。确定了新发 LBBB 的预测因素,并比较了有和无新发 LBBB 的患者的结局。新发 LBBB 发生在 1151 例患者中的 121 例(10.5%),且超过一半的患者在 6 个月至 1 年内持续存在。新发 LBBB 的唯一预测因素是既往冠状动脉旁路移植术。新发 LBBB 与 1 年死亡率、心血管死亡率、再住院、卒中和心肌梗死无显著差异。然而,新发 LBBB 与住院期间(8.3%比 2.8%,P = 0.005)和出院至 1 年期间(4.7%比 1.5%,P = 0.01)PPI 的增加相关。新发 LBBB 患者的射血分数在 TAVR 后未能改善,且在 6 个月至 1 年内仍较低(52.8%比 58.1%,P < 0.001)。
在 PARTNER 经验中,无室内基线传导的 TAVR 患者中,新发持续性 LBBB 的发生率为 10.5%。新发 LBBB 与 1 年死亡、再住院、卒中和心肌梗死无关,但与 PPI 发生率较高和左心室射血分数改善失败相关。